• Home
  • Search Results
  • Multivariate Control of Effective Cobalt Doping in Tungsten Disulfide for Highly Efficient Hydrogen Evolution Reaction.

Multivariate Control of Effective Cobalt Doping in Tungsten Disulfide for Highly Efficient Hydrogen Evolution Reaction.

Scientific reports (2019-02-06)
Liyan Zhou, Shancheng Yan, Haizeng Song, Han Wu, Yi Shi
ABSTRACT

Tungsten Disulfide (WS2) is considered to be a promising Hydrogen Evolution Reaction (HER) catalyst to replace noble metals (such as Pt and Pd). However, progress in WS2 research has been impeded by the inertness of the in-plane atoms during HER. Although it is known that microstructure and defects strongly affect the electrocatalytic performance of catalysts, the understanding of such related catalytic origin still remains a challenge. Here, we combined a one-pot synthesis method with wet chemical etching to realize controlled cobalt doping and tunable morphology in WS2. The etched products, which composed of porous WS2, CoS2 and a spot of WOx, show a low overpotential and small Tafel slope in 0.5 M H2SO4 solution. The overpotential could be optimized to -134 mV (at 10 mA/cm2) with a Tafel slope of 76 mV/dec at high loadings (5.1 mg/cm2). Under N2 adsorption analysis, the treated WS2 sample shows an increase in macropore (>50 nm) distributions, which may explain the increase inefficiency of HER activity. We applied electron holography to analyze the catalytic origin and found a low surface electrostatic potential in Co-doped region. This work may provide further understanding of the HER mechanism at the nanometer scale, and open up new avenues for designing catalysts based on other transition metal dichalcogenides for highly efficient HER.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Tungsten(VI) chloride, ≥99.9% trace metals basis

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.